| Faculty |
Title |
Fiscal Year |
| Thomas Meade, PhD, Chemistry |
The Design and Synthesis of Prodrug-Procontrast Theragnostic Probes |
2008 |
| Richard Silverman, PhD, Chemistry |
New Therapeutics for the Treatment of Parkinson’s Disease |
2008 |
| Vadim Backman, PhD, Biomedical Engineering |
Use of Novel Optics Technology to Establish Susceptibility, Resistance and Recovery Indicators of Stony Corals to Bleaching |
2008 |
| Karl Scheidt, PhD, Chemistry |
Drug Discovery for Cancer Metastasis: From Natural Product to Drug in Man |
2008 |
| Vadim Backman, PhD, Biomedical Engineering |
Lung Cancer Screening via Analysis of Nanoarchitecture of Buccal Mucosa |
2009 |
| Philip Messersmith, PhD, Biomedical Engineering |
Molecular Basis of Self-Healing in Tissues Containing Histidine-Rich Proteins |
2009 |
| Thomas O’Halloran, PHD, Chemistry & Teresa Woodruff, PHD, Obstetrics-Gynecology |
Cadium Interferences with Signaling Pathways in the Mammalian Oocyte |
2009 |
| Guillermo Ameer, PHD, Biomedical Engineering & Jason Wertheim, MD, PhD, Surgery |
Conferring thromboresistance to decellularized vascular grafts |
2012 |
| Eric Weiss, PhD, Molecular Biosciences |
Genome-scale identification of protein kinase docking interactions |
2012 |
| T. David Harris, PhD,Chemistry & Andrew Larson, PhD, Radiology |
Iron-Based Molecular MRI Thermometers for Monitoring Tumor Ablation Therapy |
2014 |
| Erik Anderson, PhD, Molecular Biosciences & Tom O’Halloran, PhD, Chemistry |
Using perturbations of heavy metal homeostasis to treat nematode-borne neglected tropical diseases |
2014 |
| Karl Scheidt, OhD, Chemistry & Herb Meltzer, MD, Psychiatry |
Development of Alstonine-based Treatments for Schizophrenia |
2014 |
| Neda Bagheri, PhD, Biomedical Engineering & Josh Leonard, PhD, Chemical Engineering |
Identifying Network-Level Signatures of Tumor-Induced Macrophage Functional Heterogeneity |
2015 |
| Teri Odom & Igal Szleifer |
Understanding Targeting and Binding of Therapeutic Nanoparticles to Plasma Membranes |
2015 |
| Alexander Statsyuk, PhD, Chemistry |
Targeting the Ubiquitin System: Nedd4-1 Ubiquitin Ligase as a Promising Drug Target |
2015 |
| Yevgenia Kozovoristkiy, PhD, Neurobiology, & Tom Meade, PhD, Chemistry |
Photochemical interrogation of synaptogenesis |
2016 |
| Karl Scheidt, PhD, Chemistry & Geoff Swanson, PhD, Pharmacology |
Exploiting nature’s pharmacopeia: mellpaladines as new serotonin antagonists |
2016 |
| Julius Lucks, PhD, Chemical and Biological Engineering & Yuan He, Phd, PhD, Molecular Biosciences |
Towards Elucidating RNA Cotranscriptional Folding Pathways from RNA Polymerase |
2017 |
| Evan Scott, Tom Meade & Vinayak Dravid |
Immunotheranostic Nanostructures for the Early Detection and Treatment of Cardiovascular Disease |
2017 |
| Hao Zhang,PhD, Biomedical Engineering &Tom O’Halloran, PhD, Chemistry & John Troy, PhD, Biomedical Engineering |
Optical Ultrastructural Investigation of Neuroprotection from Zinc in Experimental Glaucoma |
2018 |
| T David Harris, PhD, Chemistry & Irawati Kandela, PhD, Pharmacology |
Cobalt-based molecular MR probes for imaging the extracellular pH of tumors |
2018 |
| Neha Kamat, PhD, Biomedical Engineering & Julius Lucks, PhD, Chemical and Biological Engineering |
Programming vesicles to detect and record environmental signals in biological fluids |
2019 |
| Nathan Giannesch, PhD, Chemistry & Hao Zhang, PhD, Biomedical Engineering |
Enzyme-Directed Assembly of Particle Immunotherapeutics (EDAPI) – A Strategy for Engineering Tumor Microenvironments for Cancer Therapy |
2019 |
| Keith Tyo, PhD, Chemical and Biological Engineering and Tom Meade, PhD, Chemistry |
Protein circuit-based diagnostics with improved sensitivity and quantitative power |
2019 |
| Monica Olvera de la Cruz, PHD, Materials Science and Engineering, Chemistry & Danielle Tullman-Ercek, PhD, Chemical and Biological Engineering |
PET Degradation and Recycling with Enhanced Enzymatic Action |
2020 |
| Joshua Leonard, PhD, Chemical and Biological Engineering & Danielle Tullman-Ercek, PhD, Chemical and Biological Engineering |
A platform enabling self-assembling synthetic viral nanoparticles for gene delivery |
2022 |
| P. Hande Ozdinler, PhD, Neurology & Neil Kelleher, PhD, Chemistry, Molecular Biosciences, and Medicine |
The Proteoform Landscape of TDP-43 pathology in ALS Brain |
2022 |
| Xiaoyu Zhang, PhD, Chemistry |
Elucidating the essentiality and druggability of cancer acquired cysteines for developing cancer-specific therapy |
2023 |
| Gabriel Rocklin,PhD, Pharmacology & Shana Kelley, PhD, Chemistry & Joshua Leonard, PhD, Chemical and Biological Engineering |
A transdisciplinary approach to bring protein drugs to new targets |
2023 |
